Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Infinity Pharmaceuticals stock (INFI)

Buy Infinity Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Infinity Pharmaceuticals is a biotechnology business based in the US. Infinity Pharmaceuticals shares (INFI) are listed on the NASDAQ and all prices are listed in US Dollars. Infinity Pharmaceuticals employs 30 staff and has a trailing 12-month revenue of around $2.6 million.

Our top picks for where to buy Infinity Pharmaceuticals stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Infinity Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – INFI. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Infinity Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
★★★★★
Stocks, ETFs, Cryptocurrency
$0
$0
4.5%
N/A
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Infinity Pharmaceuticals stock price (NASDAQ: INFI)

Use our graph to track the performance of INFI stocks over time.

Infinity Pharmaceuticals shares at a glance

Information last updated 2024-01-28.
Latest market close$0.00
52-week range$0.00 - $0.19
50-day moving average $0.06
200-day moving average $0.23
Wall St. target price$0.30
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.44

Is it a good time to buy Infinity Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Infinity Pharmaceuticals price performance over time

Historical closes compared with the close of $0 from 2023-12-20

1 week (2024-07-11) nan%
1 month (2024-06-18) nan%
3 months (2024-04-18) nan%
6 months (2024-01-18) nan%
1 year (2023-07-21) -100.00%
2 years (2022-07-22) -100.00%
3 years (2021-07-22) 2.53
5 years (2019-07-22) 1.67

Infinity Pharmaceuticals financials

Revenue TTM $2.6 million
Gross profit TTM $-31,381,000
Return on assets TTM -60.7%
Return on equity TTM -3521.35%
Profit margin 0%
Book value $-0.41
Market Capitalization $726,088

TTM: trailing 12 months

Infinity Pharmaceuticals share dividends

We're not expecting Infinity Pharmaceuticals to pay a dividend over the next 12 months.

Have Infinity Pharmaceuticals's shares ever split?

Infinity Pharmaceuticals's shares were split on a 1:4 basis on 12 September 2006. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Infinity Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Infinity Pharmaceuticals shares which in turn could have impacted Infinity Pharmaceuticals's share price.

Infinity Pharmaceuticals share price volatility

Over the last 12 months, Infinity Pharmaceuticals's shares have ranged in value from as little as $0.0027 up to $0.1863. A popular way to gauge a stock's volatility is its "beta".

INFI.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Infinity Pharmaceuticals's is 1.3804. This would suggest that Infinity Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Infinity Pharmaceuticals overview

Infinity Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc.

Frequently asked questions

null
What percentage of Infinity Pharmaceuticals is owned by insiders or institutions?
Currently 2.356% of Infinity Pharmaceuticals shares are held by insiders and 23.485% by institutions.
How many people work for Infinity Pharmaceuticals?
Latest data suggests 30 work at Infinity Pharmaceuticals.
When does the fiscal year end for Infinity Pharmaceuticals?
Infinity Pharmaceuticals's fiscal year ends in December.
Where is Infinity Pharmaceuticals based?
Infinity Pharmaceuticals's address is: 1100 Massachusetts Avenue, Cambridge, MA, United States, 02138
What is Infinity Pharmaceuticals's ISIN number?
Infinity Pharmaceuticals's international securities identification number is: US45665G3039
What is Infinity Pharmaceuticals's CUSIP number?
Infinity Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 254675101

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site